Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New horizons in genitourinary oncologic imaging.

H Hricak1

  • 1Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Room C-278, New York, NY 10021, USA. hricakh@mskcc.org

Abdominal Imaging
|December 8, 2005
PubMed
Summary

Advanced imaging techniques like magnetic resonance imaging (MRI) and magnetic resonance spectroscopic imaging (MRSI) are revolutionizing prostate cancer management. These methods enhance the evaluation of tumor characteristics, paving the way for personalized treatment strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The impact of FDG-PET/CT in the management of patients with vulvar and vaginal cancer.

Gynecologic oncology·2016
Same author

Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: critical evaluation using whole-mount pathology as standard of reference.

European radiology·2015
Same author

Volume-based quantitative FDG PET/CT metrics and their association with optimal debulking and progression-free survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery.

European radiology·2015
Same author

Retraction note to: new horizons in genitourinary oncologic imaging.

Abdominal imaging·2015
Same author

Combined PET/MR: The Real Work Has Just Started. Summary Report of the Third International Workshop on PET/MR Imaging; February 17-21, 2014, Tübingen, Germany.

Molecular imaging and biology·2015
Same author

Volume and landmark analysis: comparison of MRI measurements obtained with an endorectal coil and with a phased-array coil.

Clinical radiology·2015

Area of Science:

  • Oncologic Imaging
  • Genitourinary Imaging
  • Molecular Imaging

Background:

  • Combined anatomic and metabolic imaging is integral to current prostate cancer management.
  • Fusion of magnetic resonance imaging (MRI) and magnetic resonance spectroscopic imaging (MRSI) improves the assessment of tumor location, size, extent, and aggressiveness.

Purpose of the Study:

  • To discuss advancements in oncologic and genitourinary imaging, specifically focusing on MRI and MRSI applications in prostate cancer.
  • To review molecular imaging probes and their role in ongoing prostate cancer research.

Main Methods:

  • Overview of current clinical applications of MRI and MRSI for prostate cancer.
  • Review of molecular imaging probes used in prostate cancer research.

Related Experiment Videos

Main Results:

  • MRI and MRSI fusion enhances the evaluation of prostate cancer characteristics, aiding in patient-specific therapy.
  • Molecular imaging offers noninvasive, in vivo visualization of cellular and molecular processes relevant to cancer.

Conclusions:

  • State-of-the-art imaging, including molecular imaging, is evolving for improved prostate cancer research and clinical care.
  • Molecular imaging enables real-time monitoring, patient-specific therapy adjustment, and molecular-level disease assessment.